ArticleFrontiers in public health2025
The size distribution of nanoparticles emitted from advanced manufacturing devices impacts predicted carcinogenic potential.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced manufacturing devices such as 3D printers bring users into closer contact with processes that generate ultrafine particles or release engineered nanomaterials. While approaches to assessing the risk of lung carcinogenesis and related health effects are developing, serious questions exist regarding the impact such devices may have on human health and safety if proper actions (i.e., engineering controls including ventilation or filtration) are not taken to mitigate exposures. The size distribution of particulates emitted during fused deposition modeling (FDM) 3D printing was measured following the ANSI/CAN/UL 2904 method and associated lung cancer risk was estimated through a developing model. Particulate morphologies were assessed, identifying agglomerative and morphological characteristics which may further impact health effects. The estimation of excess lung cancer risk for 3D printer emissions based upon particle size was found to vary according to aerodynamic diameter distribution and emitted concentration, with values projected as high as 468 cases per 10,000 workers in the measured exposure scenario (1 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.